“Improving prescription drug affordability for Medicare enrollees is the core of the Inflation Reduction Act, and the next ...
Xavier Becerra is reflecting on tenure as HHS secretary. He told Scripps News, "We're leaving this country healthier and ...
As of Monday, FDA commissioner Robert Califf, Department of Health and Human Services (HHS) Secretary Xavier Becerra, ...
On its last weekday in power, the Biden Administration has chosen the next batch of drugs up for price negotiation in ...
The Centers for Medicare and Medicaid Services (CMS) has selected 15 more drugs for Medicare price negotiation, announcing ...
In a wide-ranging interview, Xavier Becerra, President Biden’s health secretary, defended his tenure and hinted that he might ...
U.S. Health and Human Services Secretary Xavier Becerra says “this is a big deal.” Drug companies oppose the program.
Federal officials are targeting the blockbuster drugs as part of their ongoing initiative to lower drug costs.
Ozempic and Wegovy, the blockbuster but costly GLP-1 drugs often used for weight loss, are among the 15 medications that will ...
The Biden administration released another list of prescriptions drugs that would be subject to price controls. The price ...
The talks around drugs including Novo Nordisk’s Wegovy, GSK’s Trelegy Ellipta, and Pfizer’s Xtandi will set Medicare prices ...
The Biden administration says popular weight loss drugs like Ozempic and Wegovy have been added to Medicare’s list of ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback